Lv51
1240 积分 2025-07-08 加入
IDF23-0254 A Phase 1, Dose-Escalation Study of a Novel dual GIP and GLP-1 receptor agonist (HS-20094) in Healthy Chinese Subjects
13天前
已关闭
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
25天前
已完结
高危高尿酸血症药物降尿酸治疗专家共识
1个月前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
1个月前
已完结
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
1个月前
已完结
代谢性疾病的管理：关注机体异位脂肪沉积
1个月前
已完结
Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical Trial
1个月前
已完结
成人阻塞性睡眠呼吸暂停高危人群筛查与管理专家共识
2个月前
已完结
成人阻塞性睡眠呼吸暂停多学科诊疗指南
4个月前
已完结
皖公网安备34019202002308
